JOHANNESBURG - Wits University has teamed up with the pharmaceutical company Biovac to reinforce the country's vaccine production capabilities.
The collaboration will see viral-vectored vaccines being produced in South Africa.
These vaccine types use the body' cells to develop antibodies to fight the virus.
Patrick Arbuthnot said: "Basically the way it is working is that we have got expertise. We have got experience in making in making these engineer viruses. This is quite a specialised technology.
"I don’t think many other people in SA work on this. What we are doing is we transfer technology to Biovac so that they will have the capability to produce this engineered virus...once they have this they will incorporate these to their production facilities ..hopeful produce vaccine for SA and for African population ...efficiently and more cheaply."